Volume | 795 |
|
|||||
News | - | ||||||
Day High | 9.01 | Low High |
|||||
Day Low | 8.91 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Talis Biomedical Corporation | TLIS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
9.01 | 8.91 | 9.01 | 8.91 | 8.995 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
27 | 795 | $ 8.91 | $ 7,083 | - | 4.35 - 9.60 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:00 | 3 | $ 9.02 | USD |
Talis Biomedical Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
16.23M | 1.82M | - | 2.13M | -62.01M | -34.05 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Talis Biomedical News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TLIS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.10 | 9.25 | 8.88 | 9.05 | 4,115 | -0.19 | -2.09% |
1 Month | 9.03 | 9.5299 | 8.68 | 9.01 | 5,758 | -0.12 | -1.33% |
3 Months | 9.23 | 9.60 | 7.5001 | 8.84 | 7,239 | -0.32 | -3.47% |
6 Months | 8.25 | 9.60 | 7.01 | 8.42 | 8,340 | 0.66 | 8.00% |
1 Year | 7.467 | 9.60 | 4.35 | 7.41 | 20,223 | 1.44 | 19.33% |
3 Years | 180.00 | 193.20 | 4.35 | 58.05 | 127,182 | -171.09 | -95.05% |
5 Years | 435.00 | 507.90 | 4.35 | 89.65 | 139,982 | -426.09 | -97.95% |
Talis Biomedical Description
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19. |